ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 107 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22,072 | +238.0% | 20,066 | +281.0% | 0.00% | – |
Q1 2024 | $6,531 | -36.2% | 5,267 | -45.9% | 0.00% | – |
Q4 2023 | $10,231 | -65.0% | 9,744 | +128.5% | 0.00% | -100.0% |
Q3 2023 | $29,208 | +133.2% | 4,264 | +253.0% | 0.00% | – |
Q2 2023 | $12,527 | +73588.2% | 1,208 | -41.9% | 0.00% | -100.0% |
Q1 2023 | $17 | +70.0% | 2,078 | +224.7% | 0.00% | – |
Q4 2022 | $10 | -100.0% | 640 | -91.9% | 0.00% | -100.0% |
Q3 2022 | $125,000 | -32.1% | 7,931 | -39.9% | 0.00% | -50.0% |
Q2 2022 | $184,000 | +736.4% | 13,200 | +915.4% | 0.00% | – |
Q1 2022 | $22,000 | 0.0% | 1,300 | -10.4% | 0.00% | – |
Q4 2021 | $22,000 | -81.7% | 1,451 | -78.2% | 0.00% | -100.0% |
Q3 2021 | $120,000 | -19.5% | 6,670 | -21.1% | 0.00% | -25.0% |
Q2 2021 | $149,000 | +776.5% | 8,457 | +1123.9% | 0.00% | – |
Q1 2021 | $17,000 | +750.0% | 691 | +153.1% | 0.00% | – |
Q4 2020 | $2,000 | – | 273 | +25.2% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 218 | -96.2% | 0.00% | – |
Q3 2019 | $7,000 | +16.7% | 5,774 | +510.4% | 0.00% | – |
Q1 2019 | $6,000 | -14.3% | 946 | +103.9% | 0.00% | -100.0% |
Q3 2018 | $7,000 | +600.0% | 464 | +887.2% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 47 | +74.1% | 0.00% | – |
Q3 2017 | $1,000 | -66.7% | 27 | -69.0% | 0.00% | – |
Q1 2017 | $3,000 | +50.0% | 87 | -13.0% | 0.00% | – |
Q2 2016 | $2,000 | -50.0% | 100 | -46.2% | 0.00% | -100.0% |
Q1 2016 | $4,000 | -81.8% | 186 | -77.1% | 0.00% | -75.0% |
Q4 2015 | $22,000 | – | 812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,808,034 | $29,119,313 | 14.32% |
Foresite Capital Management V, LLC | 1,258,243 | $13,047,980 | 9.53% |
GREAT POINT PARTNERS LLC | 1,941,581 | $20,134,195 | 3.94% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $35,258,000 | 3.63% |
Aisling Capital Management LP | 434,455 | $4,505,298 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 651,400 | $6,755,018 | 2.09% |
VR Adviser, LLC | 1,040,754 | $10,792,619 | 1.73% |
Ikarian Capital, LLC | 796,300 | $8,257,631 | 1.32% |
Samsara BioCapital, LLC | 696,171 | $7,219,293 | 1.27% |
BRAIDWELL LP | 2,901,194 | $30,085,382 | 0.98% |